A Recombinant Shigella flexneri Strain Expressing ETEC Heat-Labile Enterotoxin B Subunit Shows Promise for Vaccine Development via OMVs
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312535 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Josune Salvador-Erro und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Parasitology, Navarra Medical Research Institute (IdiSNA), University of Navarra, 31008 Pamplona, Spain. Hauptthemen laut MEDLINE: Enterotoxins, Shigella flexneri, Enterotoxigenic Escherichia coli, Bacterial Toxins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Gobierno de Navarra, Spain-Next Generation EU”.
Abstract (Originalsprache)
Diarrheal diseases caused by Shigella and enterotoxigenic Escherichia coli (ETEC) are significant health burdens, especially in resource-limited regions with high child mortality. In response to the lack of licensed vaccines and rising antibiotic resistance for these pathogens, this study developed a recombinant Shigella flexneri strain with the novel incorporation of the eltb gene for the heat-labile enterotoxin B (LTB) subunit of ETEC directly into Shigella’s genome, enhancing stability and consistent production. This approach combines the immunogenic potential of LTB with the antigen delivery properties of S. flexneri outer membrane vesicles (OMVs), aiming to provide cross-protection against both bacterial pathogens in a stable, non-replicating vaccine platform. We confirmed successful expression through GM1-capture ELISA, achieving levels comparable to ETEC. Additionally, proteomic analysis verified that the isolated vesicles from the recombinant strains contain the LTB protein and the main outer membrane proteins and virulence factors from Shigella, including OmpA, OmpC, IcsA, SepA, and Ipa proteins, and increased expression of Slp and OmpX. Thus, our newly designed S. flexneri OMVs, engineered to carry ETEC’s LTB toxin, represent a promising strategy to be considered as a subunit vaccine candidate against S. flexneri and ETEC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Parasitology, Navarra Medical Research Institute (IdiSNA), University of Navarra, 31008 Pamplona, Spain.
ORCID-Profile: Yadira Pastor, Carlos Gamazo
Förderung
- “Gobierno de Navarra, Spain-Next Generation EU”
Zitieren
APA
Salvador-Erro, J., Pastor, Y., & Gamazo, C. (2024). A Recombinant Shigella flexneri Strain Expressing ETEC Heat-Labile Enterotoxin B Subunit Shows Promise for Vaccine Development via OMVs. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312535
Vancouver
Salvador-Erro J, Pastor Y, Gamazo C. A Recombinant Shigella flexneri Strain Expressing ETEC Heat-Labile Enterotoxin B Subunit Shows Promise for Vaccine Development via OMVs. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312535
BibTeX
@article{SalvadorErro2024,
author = {Salvador-Erro, Josune and Pastor, Yadira and Gamazo, Carlos},
title = {A Recombinant Shigella flexneri Strain Expressing ETEC Heat-Labile Enterotoxin B Subunit Shows Promise for Vaccine Development via OMVs},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312535}
}
EUVIMED